Anti-Human CD86 (B7-2), PE (Clone:IT2.2)检测试剂
¥1,112.00 – ¥2,464.00
- 分子靶点:CD86, B7-2, CD28LG2
- 种属:人 (Human)
- 标记:PE
- 亚型:Mouse IgG2b, κ
- 克隆号:IT2.2
在售SKU, 70-AH08604-20, 70-AH08604-50, 70-AH08604-100, AH08604, 70-F1108602-25, 70-F1108602-100
商品名 |
Anti-Human CD86 (B7-2), PE (Clone:IT2.2)检测试剂 |
---|---|
靶点 | |
标记 |
PE |
仪器 |
适用488nm, 532nm, 561nm激光器的流式细胞仪 |
亚型 |
Mouse IgG2b, κ |
克隆号 |
IT2.2 |
推荐应用 |
流式检测 |
用量 |
5 μL /Test |
纯化 |
亲和层析 |
储存液 |
含 0.2% BSA 和 0.2% proclin 950 的磷酸盐缓冲液(pH7.2) |
保存条件 |
2 - 8℃避光,切勿冻存 |
结果示例

图 - 人外周血染色 Anti-Human CD86, PE (F1108602) 和 Anti-Human CD14, APC (F1101403) 的结果。以 FSC/SSC 中的淋巴细胞和单核细胞设门进行分析。
分子信息
CD86 分子靶点信息概述
- 分子名:CD86, CD86 molecule
- 基因家族:CD molecules; V-set domain containing; B7 family
- 别名:B7.2; B7-2
- 曾用名:CD28LG2
- 全称:B-lymphocyte antigen B7-2; CD86 antigen (CD28 antigen ligand 2, B7-2 antigen)
CD86 分子靶点综述
CD86也称为B7.2,分子量80 kD,表达于树突状细胞、单核细胞、记忆T淋巴细胞、生发中心B淋巴细胞、活化B淋巴细胞以及活化T淋巴细胞。属于免疫球蛋白超家族,其配体是CD28和CD152 (CTLA4)。CD86与诱导剂CD28和抑制剂CTLA4相互作用,是诱导T淋巴细胞增殖及产生IL-2的主要协同因子。
人 Human CD86 分子靶点信息
- 分子名:CD86, CD86 molecule
- 别称:
- activation B7-2 antigen
- B-lymphocyte activation antigen B7-2
- B-lymphocyte antigen B7-2
- B7-2
- B7-2 antigen
- B7.2
- B70
- BU63
- CD28 antigen ligand 2
- CD28LG2
- CD86 antigen (CD28 antigen ligand 2, B7-2 antigen)
- CTLA-4 counter-receptor B7.2
- FUN-1
- LAB72
- MGC34413
- T-lymphocyte activation antigen CD86
- 基因序列:NCBI_Gene: 942
- 蛋白序列:UniProtKB: P42081
人 Human CD86靶点分子功能(预测)
Predicted to enable signaling receptor activity. Predicted to be involved in several processes, including CD40 signaling pathway; positive regulation of macromolecule metabolic process; and regulation of T cell activation. Predicted to act upstream of or within defense response to virus and toll-like receptor signaling pathway. Located in centriolar satellite; extracellular exosome; and plasma membrane. Implicated in several diseases, including Henoch-Schoenlein purpura; autoimmune disease (multiple); chronic lymphocytic leukemia; chronic obstructive pulmonary disease; and systemic scleroderma. Biomarker of several diseases, including autoimmune disease (multiple); cryoglobulinemia; hematologic cancer (multiple); lung disease (multiple); and pulmonary hypertension.